MiMedx Group Inc.

MDXG | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.88

+$0.07 (+1.46%)

Sep 22, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.46%

(1D)

Rating

Updated: Sep 18, 2026

37.2

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $710.58M

1D Range

4.78 4.91

52W Range

3.03 7.97

Valuation (TTM)

PE 120.25

PB 3.25

EV/EBITDA 23.92

Valuation (NTM)

Forward PE 21.54

Forward PEG -0.41

Price Target $7.67

Cash Flow

FCF Yield 6.0%

SBC Adj. FCF Yield 5.0%

SBC Impact -15.7%

Margins

Gross Margin 78.8%

Operating Margin 2.5%

FCF Margin 11.8%

Growth (CAGR)

Revenue 3Y | 5Y 6.4% | 6.4%

Dil EPS 3Y | 5Y -97.1% | 79.8%

FCF 3Y | 5Y -1.4% | 67.0%

Returns

ROA 2.2%

ROE 2.6%

ROIC 1.9%

Financial Health

Net Cash

$134.34M

Current Ratio 5.33

Interest Coverage 5.50

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to...

Sector Healthcare

Industry Biotechnology

Employees 808

IPO Date Feb 11, 2008

Website www.mimedx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+63.93%

Buy (5)

Hold (0)

Sell (0)

Analyst Details ➞